![](/img/cover-not-exists.png)
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression
G. Chouinard, B.M. Saxena, N.P.V. Nair, S.P. Kutcher, D. Bakish, J. Bradwejn, S.H. Kennedy, V. Sharma, R.A. Remick, S.A. Kukha-Mohamad, M.C. Belanger, J. Snaith, L. Beauclair, Pohlmann H., J. D'SouzaVolume:
32
Year:
1994
Language:
english
DOI:
10.1016/0165-0327(94)90068-x
File:
PDF, 920 KB
english, 1994